Even in the most optimistic scenario, the coronavirus disease outbreak in the Russian Federation will last for at least two months, Georgii Bazykin, Skoltech Professor, Chair of the Molecular Evolution Sector, IITP RAS, believes According to his forecast...
Representatives of the German group of companies “Phoenix contact” and the Skolkovo Foundation laid the first stone of the partner center on the territory of the innovation center. By 2021, a regional center for development and industry competencies...
The Skolkovo Foundation has joined forces with the U.K.’s AMR Centre, a private-public initiative launched in 2016 to support and accelerate the development of new antibiotics, to combat the global problem of antimicrobial resistance. Skolkovo's...
Russia’s first commercial research biobank, National BioService , opened a brand new laboratory at the Skolkovo Technopark on Thursday. The National BioService lab at the Skolkovo Technopark will be used for both the company's own research and...
Despite the 9,000 kilometres between them, the Skolkovo innovation centre outside Moscow and Russia’s Far Eastern Federal University ( FEFU ) in Vladivostok have a lot in common. They were both created in 2010, when four of the Far East’s leading...
The first shared lab space in Russia for life sciences and biotech startups opened its doors at the Skolkovo Technopark on Wednesday with a mission to help budding biomed entrepreneurs test their theories and turn their ideas into a commercial company. ...
Russia’s official position on the potentially lucrative field of asteroid mining is that it is outlawed by the 1967 Outer Space Treaty, which declares that space is “the province of mankind,” and that its use and exploration must “benefit...
Pharm-Sintez.Lab , a resident startup of the Skolkovo Foundation’s nuclear cluster, has developed a system for detecting rare forms of cancer in Russian patients. Lev Voloznev, CEO of Pharm-Sintez.Lab, pictured in his lab at the Skolkovo Technopark...
Peter Thiel, a German-American billionaire entrepreneur and investor, caused a near-tidal wave of outrage ahead of the recent U.S. presidential election when he set himself apart from most of Silicon Valley by coming out in favour of Donald Trump. A design...
Russia’s wealth of fossil fuel resources has inevitably made it easy for the country to ignore renewable energy sources (RES). In recent years, however, several government initiatives have been launched to develop this sector, and at the REENCON-21 International...
Skolkovo startup DRD Biotech has produced a working prototype of an express test that can determine in just a few minutes whether a person has had – or is at near-term risk of having – the most common kind of stroke. Svetlana Dambinova has...
ExoAtlet , a Skolkovo startup that makes medical exoskeletons for the rehabilitation of disabled people, has started clinical research into the use of its exoskeletons to help people with multiple sclerosis. An ExoAtlet exoskeleton being demonstrated...
Iran’s Islamic Azad University will set up an R&D centre at the Skolkovo innovation centre next year, the two sides agreed at the International Association of Science Parks and Areas of Innovation (IASP) conference in Moscow on Tuesday. Under the...
If scientists invented an anti-ageing pill that would help you live to the age of 120, would you take it? Think carefully, because if it sounds like science fiction, it’s not. Ageing is a treatable disease like any other, according to some scientists...
Amid the satellites, virtual reality headsets, 3D printers and other hi-tech products on show at Skolkovo’s recent Startup Bazaar, the stand housing a cage of buzzing flies and jar of writhing maggots stood out. Also on the table were jars of dried and...
Hyperloop One, one of the companies working to make Elon Musk’s high-speed vacuum train dream a reality, sees potential for working with Skolkovo startups on the ambitious project, the U.S. company’s vice president said Thursday. Knut Sauer...
A 3D printer for use in space is the end goal of a joint project between two residents of the Skolkovo Foundation – the companies Sputnix and Anisoprint – and Moscow Polytechnic University. Fyodor Antonov, director of Anisoprint., a resident...
Albert Yefimov, head of the Skolkovo Foundation's Robotics Center, has written an article for thedisruptory.com, an online resource devoted to innovative technology including robotics, on the Russian robotics industry, popular attitudes to robots in Russia...
The Skolkovo Foundation is preparing to expand beyond planet Earth this autumn, when its subsidiary, the Skolkovo Orbital Launch Centre (SOLC), is set to send satellites into space. “Our first launches are planned for October this year,” said...
As nations across the globe marked World Cancer Day on February 4, the Skolkovo Foundation announced the creation of a new Cancer Centre of Excellence. The new centre is set to coordinate the work of all the startup companies and partners currently working...
From its beginning, one of Skoltech’s guiding principles was to interface with industrial commercialization and venture opportunities as they develop at Skolkovo and elsewhere. This week Skoltech has realized this principle, as it has signed its first...
A new 3D face recognition system developed by Skolkovo IT cluster resident Vocord FaceControl has proved flawless in testing, the company says. The biometric face recognitions system Vocord FaceControl 3D is built upon 3D machine vision, and during testing...
Skolkovo biomed cluster resident 3D Bioprinting Solutions has announced the successful printing of a mouse’s thyroid gland. 3D Bioprinting Solutions unveiled Russia's first bioprinter in October. Photo: 3D Bioprinting Solutions If confirmed...
Skolkovo resident biomed company Aelita has put a new anesthetic machine through five months of successful testing on real patients, passing a key test on the path to market entry. The machine, known as Anekom, is intended for inhalation anesthesia in combination...
A 30 million ruble grant from the Skolkovo Foundation is helping a team of Russian scientists develop potentially one of the most effective drugs yet to fight cardiovascular disease – the primary cause of death in Russia and the wider world. Dmitry...